RENEU: A PIVOTAL PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA (PN)
Meeting Abstract
Moertel, C. L.; Hirbe, A. C.; Shuhaiber, H. H.; Viskochil, D.; Sidhu, A.; Bielamowicz, K.; Weber, M. D.; Lokku, A.; Smith, L.; Weintraub, L.; McNall-Knapp, R. Y.; Hajjar, F. M.; Foreman, N.; Gershon, T. R.; Babovic-Vuksanovic, D.